
Sign up to save your podcasts
Or


This episode of The Drug Report takes a look at a COVID-19 cocktail comprised of the coadministration of casirivimab and imdevimab, which has proven to decrease hospitalization and emergency room visits.
Published November 30, 2020
By ReachMDThis episode of The Drug Report takes a look at a COVID-19 cocktail comprised of the coadministration of casirivimab and imdevimab, which has proven to decrease hospitalization and emergency room visits.
Published November 30, 2020